Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_assertion evidence source_evidence_literature NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_assertion SIO_000772 12514133 NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_assertion wasDerivedFrom befree-20140225 NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_assertion wasGeneratedBy ECO_0000203 NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.